{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T17:21:17Z","timestamp":1785345677186,"version":"3.55.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Nephrol"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s00467-024-06572-6","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T12:48:12Z","timestamp":1738759692000},"page":"2469-2479","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Post-transplant diarrhea in pediatric kidney transplant recipients"],"prefix":"10.1007","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-5819-1432","authenticated-orcid":false,"given":"Machi Kaneko","family":"McBee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lavjay","family":"Butani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"6572_CR1","doi-asserted-by":"publisher","first-page":"2190","DOI":"10.1016\/j.transproceed.2007.07.015","volume":"39","author":"S Gil-Vernet","year":"2007","unstructured":"Gil-Vernet S, Amado A, Ortega F et al (2007) Gastrointestinal complications in renal transplant recipients: MITOS study. Transplant Proc 39:2190\u20132193. https:\/\/doi.org\/10.1016\/j.transproceed.2007.07.015","journal-title":"Transplant Proc"},{"key":"6572_CR2","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00467-018-3951-1","volume":"34","author":"FA Scaggs Huang","year":"2019","unstructured":"Scaggs Huang FA, Danziger-Isakov L (2019) Infectious disease risks in pediatric renal transplantation. Pediatr Nephrol 34:1155\u20131166. https:\/\/doi.org\/10.1007\/s00467-018-3951-1","journal-title":"Pediatr Nephrol"},{"key":"6572_CR3","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1053\/j.ajkd.2007.11.013","volume":"51","author":"S Bunnapradist","year":"2008","unstructured":"Bunnapradist S, Neri L, Wong W et al (2008) Incidence and risk factors for diarrhea following kidney transplantation and association with graft loss and mortality. Am J Kidney Dis 51:478\u2013486. https:\/\/doi.org\/10.1053\/j.ajkd.2007.11.013","journal-title":"Am J Kidney Dis"},{"key":"6572_CR4","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000027625","volume":"100","author":"J Phrommas","year":"2021","unstructured":"Phrommas J, Tanpowpong P, Getsuwan S et al (2021) Diarrhea in pediatric recipients of solid organ or bone marrow transplants. Medicine (Baltimore) 100:e27625. https:\/\/doi.org\/10.1097\/MD.0000000000027625","journal-title":"Medicine (Baltimore)"},{"key":"6572_CR5","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/01.tp.0000251923.14697.f5","volume":"83","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Kyll\u00f6nen L, Madsen S et al (2007) Increased prevalence of gastrointestinal symptoms associated with impaired quality of life in renal transplant recipients. Transplantation 83:282\u2013289. https:\/\/doi.org\/10.1097\/01.tp.0000251923.14697.f5","journal-title":"Transplantation"},{"key":"6572_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/01.tp.0000284983.89207.1a","volume":"84","author":"H Ekberg","year":"2007","unstructured":"Ekberg H, Kyll\u00f6nen L, Madsen S et al (2007) Clinicians underestimate gastrointestinal symptoms and overestimate quality of life in renal transplant recipients: a multinational survey of nephrologists. Transplantation 84:1052\u20131054. https:\/\/doi.org\/10.1097\/01.tp.0000284983.89207.1a","journal-title":"Transplantation"},{"key":"6572_CR7","doi-asserted-by":"publisher","first-page":"252","DOI":"10.3390\/toxins13040252","volume":"13","author":"J Rysz","year":"2021","unstructured":"Rysz J, Franczyk B, \u0141awi\u0144ski J et al (2021) The impact of CKD on uremic toxins and gut microbiota. Toxins 13:252. https:\/\/doi.org\/10.3390\/toxins13040252","journal-title":"Toxins"},{"key":"6572_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/TP.0000000000001492","volume":"101","author":"J Tourret","year":"2017","unstructured":"Tourret J, Willing BP, Dion S et al (2017) Immunosuppressive treatment alters secretion of ileal antimicrobial peptides and gut microbiota, and favors subsequent colonization by uropathogenic Escherichia coli. Transplantation 101:74\u201382. https:\/\/doi.org\/10.1097\/TP.0000000000001492","journal-title":"Transplantation"},{"key":"6572_CR9","doi-asserted-by":"publisher","first-page":"386","DOI":"10.3390\/jcm9020386","volume":"9","author":"JC Swarte","year":"2020","unstructured":"Swarte JC, Douwes RM, Hu S et al (2020) Characteristics and dysbiosis of the gut microbiome in renal transplant recipients. J Clin Med 9:386. https:\/\/doi.org\/10.3390\/jcm9020386","journal-title":"J Clin Med"},{"key":"6572_CR10","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1097\/TP.0000000000000370","volume":"98","author":"JR Lee","year":"2014","unstructured":"Lee JR, Muthukumar T, Dadhania D et al (2014) Gut microbial community structure and complications after kidney transplantation: a pilot study. Transplantation 98:697\u2013705. https:\/\/doi.org\/10.1097\/TP.0000000000000370","journal-title":"Transplantation"},{"key":"6572_CR11","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1111\/ajt.14974","volume":"19","author":"JR Lee","year":"2019","unstructured":"Lee JR, Magruder M, Zhang L et al (2019) Gut microbiota dysbiosis and diarrhea in kidney transplant recipients. Am J Transplant 19:488\u2013500. https:\/\/doi.org\/10.1111\/ajt.14974","journal-title":"Am J Transplant"},{"key":"6572_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14260","volume":"35","author":"LT Zhang","year":"2021","unstructured":"Zhang LT, Westblade LF, Iqbal F et al (2021) Gut microbiota profiles and fecal beta-glucuronidase activity in kidney transplant recipients with and without post-transplant diarrhea. Clin Transplant 35:e14260. https:\/\/doi.org\/10.1111\/ctr.14260","journal-title":"Clin Transplant"},{"key":"6572_CR13","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ekir.2020.10.013","volume":"6","author":"S Chan","year":"2021","unstructured":"Chan S, Cao C, Pascoe EM et al (2021) Patient-reported gastrointestinal symptoms and the association with quality of life following kidney transplantation. Kidney Int Rep 6:138\u2013145. https:\/\/doi.org\/10.1016\/j.ekir.2020.10.013","journal-title":"Kidney Int Rep"},{"key":"6572_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13717","volume":"24","author":"PS Verghese","year":"2020","unstructured":"Verghese PS, Chinnakotla S, Berglund D et al (2020) Re-hospitalization after pediatric kidney transplant: a single-center study. Pediatr Transplant 24:e13717. https:\/\/doi.org\/10.1111\/petr.13717","journal-title":"Pediatr Transplant"},{"key":"6572_CR15","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1111\/j.1399-0012.2005.00421.x","volume":"19","author":"J Tierce","year":"2005","unstructured":"Tierce J, Porterfield-Baxa J, Petrilla A et al (2005) Impact of mycophenolate mofetil (MMF)-related gastrointestinal complications and MMF dose alterations on transplant outcomes and healthcare costs in renal transplant recipients. Clin Transplant 19:779\u2013784. https:\/\/doi.org\/10.1111\/j.1399-0012.2005.00421.x","journal-title":"Clin Transplant"},{"key":"6572_CR16","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1097\/00007890-200607152-01249","volume":"82","author":"SK Takemoto","year":"2006","unstructured":"Takemoto SK, Pinsky B, Lentine K et al (2006) Poor immunosuppression adherence: associated factors and possible consequences. Transplantation 82:488","journal-title":"Transplantation"},{"key":"6572_CR17","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14628","volume":"28","author":"A Moudgil","year":"2024","unstructured":"Moudgil A, Sgambat K, Benoit E et al (2024) Prevalence of mycophenolate mofetil discontinuation and subsequent outcomes in pediatric kidney transplant recipients: a PNRC study. Pediatr Transplant 28:e14628. https:\/\/doi.org\/10.1111\/petr.14628","journal-title":"Pediatr Transplant"},{"key":"6572_CR18","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1034\/j.1399-0012.2003.00026.x","volume":"17","author":"RP Pelletier","year":"2003","unstructured":"Pelletier RP, Akin B, Henry ML et al (2003) The impact of mycophenolate mofetil dosing patterns on clinical outcome after renal transplantation. Clin Transplant 17:200\u2013205. https:\/\/doi.org\/10.1034\/j.1399-0012.2003.00026.x","journal-title":"Clin Transplant"},{"key":"6572_CR19","doi-asserted-by":"publisher","first-page":"2381","DOI":"10.1097\/01.ASN.0000079616.71891.F5","volume":"14","author":"GA Knoll","year":"2003","unstructured":"Knoll GA, MacDonald I, Khan A, Van Walraven C (2003) Mycophenolate mofetil dose reduction and the risk of acute rejection after renal transplantation. J Am Soc Nephrol 14:2381\u20132386. https:\/\/doi.org\/10.1097\/01.ASN.0000079616.71891.F5","journal-title":"J Am Soc Nephrol"},{"key":"6572_CR20","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1542\/pir.2015-0099","volume":"37","author":"NJ CaJacob","year":"2016","unstructured":"CaJacob NJ, Cohen MB (2016) Update on diarrhea. Pediatr Rev 37:313\u2013322. https:\/\/doi.org\/10.1542\/pir.2015-0099","journal-title":"Pediatr Rev"},{"key":"6572_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040098","volume":"4","author":"S-TT Li","year":"2007","unstructured":"Li S-TT, Grossman DC, Cummings P (2007) Loperamide therapy for acute diarrhea in children: systematic review and meta-analysis. PLoS Med 4:e98. https:\/\/doi.org\/10.1371\/journal.pmed.0040098","journal-title":"PLoS Med"},{"key":"6572_CR22","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1016\/j.mayocpiqo.2020.06.005","volume":"4","author":"C Kuon","year":"2020","unstructured":"Kuon C, Wannier R, Sterken D et al (2020) Are antimotility agents safe for use in clostridioides difficile infections? Results from an observational study in malignant hematology patients. Mayo Clin Proc Innov Qual Outcomes 4:792\u2013800. https:\/\/doi.org\/10.1016\/j.mayocpiqo.2020.06.005","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"6572_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1034\/j.1399-3046.2000.00086.x","volume":"4","author":"SK Eades","year":"2000","unstructured":"Eades SK, Boineau FG, Christensen ML (2000) Increased tacrolimus levels in a pediatric renal transplant patient attributed to chronic diarrhea. Pediatr Transplant 4:63\u201366. https:\/\/doi.org\/10.1034\/j.1399-3046.2000.00086.x","journal-title":"Pediatr Transplant"},{"key":"6572_CR24","doi-asserted-by":"publisher","first-page":"965","DOI":"10.1007\/s00467-009-1402-8","volume":"25","author":"S Leroy","year":"2010","unstructured":"Leroy S, Isapof A, Fargue S et al (2010) Tacrolimus nephrotoxicity: beware of the association of diarrhea, drug interaction and pharmacogenetics. Pediatr Nephrol 25:965\u2013969. https:\/\/doi.org\/10.1007\/s00467-009-1402-8","journal-title":"Pediatr Nephrol"},{"key":"6572_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1111\/j.1399-0012.2004.00232.x","volume":"18","author":"K Sato","year":"2004","unstructured":"Sato K, Amada N, Sato T et al (2004) Severe elevations of FK506 blood concentration due to diarrhea in renal transplant recipients. Clin Transplant 18:585\u2013590. https:\/\/doi.org\/10.1111\/j.1399-0012.2004.00232.x","journal-title":"Clin Transplant"},{"key":"6572_CR26","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1016\/j.advnut.2023.06.008","volume":"14","author":"R Costello","year":"2023","unstructured":"Costello R, Rosanoff A, Nielsen F, West C (2023) Perspective: call for re-evaluation of the tolerable upper intake level for magnesium supplementation in adults. Adv Nutr 14:973\u2013982. https:\/\/doi.org\/10.1016\/j.advnut.2023.06.008","journal-title":"Adv Nutr"},{"key":"6572_CR27","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1097\/00007890-200103150-00010","volume":"71","author":"A Staskewitz","year":"2001","unstructured":"Staskewitz A, Kirste G, T\u00f6nshoff B et al (2001) Mycophenolate mofetil in pediatric renal transplantation without induction therapy: results after 12 months of treatment. Transplantation 71:638\u2013644. https:\/\/doi.org\/10.1097\/00007890-200103150-00010","journal-title":"Transplantation"},{"key":"6572_CR28","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s004670050020","volume":"14","author":"E Jacqz-Aigrain","year":"2000","unstructured":"Jacqz-Aigrain E, Khan Shaghaghi E, Baudouin V et al (2000) Pharmacokinetics and tolerance of mycophenolate mofetil in renal transplant children. Pediatr Nephrol 14:95\u201399. https:\/\/doi.org\/10.1007\/s004670050020","journal-title":"Pediatr Nephrol"},{"key":"6572_CR29","doi-asserted-by":"publisher","first-page":"e.6774","DOI":"10.7759\/cureus.6774","volume":"12","author":"R Farooqi","year":"2020","unstructured":"Farooqi R, Kamal A, Burke C (2020) Mycophenolate-induced colitis: a case report with focused review of literature. Cureus 12:e.6774. https:\/\/doi.org\/10.7759\/cureus.6774","journal-title":"Cureus"},{"key":"6572_CR30","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.healun.2018.05.002","volume":"37","author":"KL Flannigan","year":"2018","unstructured":"Flannigan KL, Taylor MR, Pereira SK et al (2018) An intact microbiota is required for the gastrointestinal toxicity of the immunosuppressant mycophenolate mofetil. J Heart Lung Transplant 37:1047\u20131059. https:\/\/doi.org\/10.1016\/j.healun.2018.05.002","journal-title":"J Heart Lung Transplant"},{"key":"6572_CR31","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1016\/j.transproceed.2021.06.020","volume":"53","author":"S Sekmek","year":"2021","unstructured":"Sekmek S, Yildirim T, Koc NS et al (2021) Efficacy and safety of switching to azathioprine for mycophenolate-induced diarrhea in renal transplant recipients. Transplant Proc 53:1951\u20131956. https:\/\/doi.org\/10.1016\/j.transproceed.2021.06.020","journal-title":"Transplant Proc"},{"key":"6572_CR32","doi-asserted-by":"publisher","first-page":"S166","DOI":"10.1016\/j.healun.2004.12.092","volume":"24","author":"JA Kobashigawa","year":"2005","unstructured":"Kobashigawa JA, Renlund DG, Gerosa G et al (2005) Twelve months results of enteric-coated mycophenolate sodium (EC-MPS) in de novo heart transplant patients showed excellent efficacy and safety. J Heart Lung Transplant 24:S166. https:\/\/doi.org\/10.1016\/j.healun.2004.12.092","journal-title":"J Heart Lung Transplant"},{"key":"6572_CR33","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1016\/j.transproceed.2011.01.184","volume":"43","author":"P Reinke","year":"2011","unstructured":"Reinke P, Budde K, Hugo C et al (2011) Reduction of gastrointestinal complications in renal graft recipients after conversion from mycophenolate mofetil to enteric-coated mycophenolate sodium. Transplant Proc 43:1641\u20131646. https:\/\/doi.org\/10.1016\/j.transproceed.2011.01.184","journal-title":"Transplant Proc"},{"key":"6572_CR34","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1472-8206.2009.00711.x","volume":"23","author":"M Sabbatini","year":"2009","unstructured":"Sabbatini M, Capone D, Gallo R et al (2009) EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects. Fundam Clin Pharmacol 23:617\u2013624. https:\/\/doi.org\/10.1111\/j.1472-8206.2009.00711.x","journal-title":"Fundam Clin Pharmacol"},{"key":"6572_CR35","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/his.12222","volume":"63","author":"G Liapis","year":"2013","unstructured":"Liapis G, Boletis J, Skalioti C et al (2013) Histological spectrum of mycophenolate mofetil-related colitis: association with apoptosis. Histopathology 63:649\u2013658. https:\/\/doi.org\/10.1111\/his.12222","journal-title":"Histopathology"},{"key":"6572_CR36","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1097\/MCG.0b013e3181a8754d","volume":"43","author":"UP Phatak","year":"2009","unstructured":"Phatak UP, Seo-Mayer P, Jain D et al (2009) Mycophenolate mofetil-induced colitis in children. J Clin Gastroenterol 43:967\u2013969. https:\/\/doi.org\/10.1097\/MCG.0b013e3181a8754d","journal-title":"J Clin Gastroenterol"},{"key":"6572_CR37","doi-asserted-by":"publisher","first-page":"4795","DOI":"10.1182\/blood.V128.22.4795.4795","volume":"128","author":"P Dhakal","year":"2016","unstructured":"Dhakal P, Gami R, Giri S, Bhatt VR (2016) Mycophenolate mofetil (MMF)-induced colitis. Blood 128:4795\u20134795. https:\/\/doi.org\/10.1182\/blood.V128.22.4795.4795","journal-title":"Blood"},{"key":"6572_CR38","doi-asserted-by":"publisher","unstructured":"Webster A, Woodroffe RC, Taylor RS et al (2005) Tacrolimus versus cyclosporin as primary immunosuppression for kidney transplant recipients. Cochrane Database Syst Rev CD003961. https:\/\/doi.org\/10.1002\/14651858.CD003961.pub2","DOI":"10.1002\/14651858.CD003961.pub2"},{"key":"6572_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1097\/PAS.0000000000001761","volume":"46","author":"E Hissong","year":"2022","unstructured":"Hissong E, Mostyka M, Yantiss RK (2022) Histologic features of tacrolimus-induced colonic injury. Am J Surg Pathol 46:118. https:\/\/doi.org\/10.1097\/PAS.0000000000001761","journal-title":"Am J Surg Pathol"},{"key":"6572_CR40","doi-asserted-by":"publisher","first-page":"604","DOI":"10.3201\/eid1604.090680","volume":"16","author":"MD Zilberberg","year":"2010","unstructured":"Zilberberg MD, Tillotson GS, McDonald C (2010) Clostridium difficile infections among hospitalized children, United States, 1997\u20132006. Emerg Infect Dis 16:604\u2013609. https:\/\/doi.org\/10.3201\/eid1604.090680","journal-title":"Emerg Infect Dis"},{"key":"6572_CR41","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1111\/tid.12584","volume":"18","author":"J Ciricillo","year":"2016","unstructured":"Ciricillo J, Haslam D, Blum S et al (2016) Frequency and risks associated with C lostridium difficile -associated diarrhea after pediatric solid organ transplantation: a single-center retrospective review. Transpl Infect Dis 18:706\u2013713. https:\/\/doi.org\/10.1111\/tid.12584","journal-title":"Transpl Infect Dis"},{"key":"6572_CR42","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13149","volume":"21","author":"E Ochfeld","year":"2019","unstructured":"Ochfeld E, Balmert LC, Patel SJ et al (2019) Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children. Transpl Infect Dis 21:e13149. https:\/\/doi.org\/10.1111\/tid.13149","journal-title":"Transpl Infect Dis"},{"key":"6572_CR43","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/cid\/cix1085","volume":"66","author":"LC McDonald","year":"2018","unstructured":"McDonald LC, Gerding DN, Johnson S et al (2018) Clinical practice guidelines for Clostridium difficile infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). Clin Infect Dis 66:e1\u2013e48. https:\/\/doi.org\/10.1093\/cid\/cix1085","journal-title":"Clin Infect Dis"},{"key":"6572_CR44","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2023-062307","volume":"152","author":"D-A Shirley","year":"2023","unstructured":"Shirley D-A, Tornel W, Warren CA, Moonah S (2023) Clostridioides difficile infection in children: recent updates on epidemiology, diagnosis, therapy. Pediatrics 152:e2023062307. https:\/\/doi.org\/10.1542\/peds.2023-062307","journal-title":"Pediatrics"},{"key":"6572_CR45","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1093\/cid\/ciz1149","volume":"71","author":"J Wolf","year":"2019","unstructured":"Wolf J, Kalocsai K, Fortuny C et al (2019) Safety and efficacy of fidaxomicin and vancomycin in children and adolescents with Clostridioides (Clostridium) difficile infection: a phase 3, multicenter, randomized, single-blind clinical trial (SUNSHINE). Clin Infect Dis 71:2581\u20132588. https:\/\/doi.org\/10.1093\/cid\/ciz1149","journal-title":"Clin Infect Dis"},{"key":"6572_CR46","doi-asserted-by":"publisher","first-page":"2524","DOI":"10.1093\/jac\/dky182","volume":"73","author":"T Birch","year":"2018","unstructured":"Birch T, Golan Y, Rizzardini G et al (2018) Efficacy of bezlotoxumab based on timing of administration relative to start of antibacterial therapy for Clostridium difficile infection. J Antimicrob Chemother 73:2524\u20132528. https:\/\/doi.org\/10.1093\/jac\/dky182","journal-title":"J Antimicrob Chemother"},{"key":"6572_CR47","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/cid\/ciy171","volume":"67","author":"DN Gerding","year":"2018","unstructured":"Gerding DN, Kelly CP, Rahav G et al (2018) Bezlotoxumab for prevention of recurrent Clostridium difficile infection in patients at increased risk for recurrence. Clin Infect Dis 67:649\u2013656. https:\/\/doi.org\/10.1093\/cid\/ciy171","journal-title":"Clin Infect Dis"},{"key":"6572_CR48","doi-asserted-by":"publisher","unstructured":"Mullane KM, Dubberke ER, AST ID Community of Practice (2019) Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: guidelines from the American Society of Transplantation Community of Practice. Clin Transplant 33:e13564. https:\/\/doi.org\/10.1111\/ctr.13564","DOI":"10.1111\/ctr.13564"},{"key":"6572_CR49","doi-asserted-by":"publisher","first-page":"e1029","DOI":"10.1093\/cid\/ciab549","volume":"73","author":"S Johnson","year":"2021","unstructured":"Johnson S, Lavergne V, Skinner AM et al (2021) Clinical practice guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 focused update guidelines on management of Clostridioides difficile infection in adults. Clin Infect Dis 73:e1029\u2013e1044. https:\/\/doi.org\/10.1093\/cid\/ciab549","journal-title":"Clin Infect Dis"},{"key":"6572_CR50","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1093\/jpids\/piad031","volume":"12","author":"TJ Sferra","year":"2023","unstructured":"Sferra TJ, Merta T, Neely M et al (2023) Double-blind, placebo-controlled study of bezlotoxumab in children receiving antibacterial treatment for Clostridioides difficile infection (MODIFY III). J Pediatr Infect Dis Soc 12:334\u2013341. https:\/\/doi.org\/10.1093\/jpids\/piad031","journal-title":"J Pediatr Infect Dis Soc"},{"key":"6572_CR51","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1515\/med-2020-0130","volume":"15","author":"A Calogero","year":"2020","unstructured":"Calogero A, Gallo M, Sica A et al (2020) Gastroenterological complications in kidney transplant patients. Open Med 15:623\u2013634. https:\/\/doi.org\/10.1515\/med-2020-0130","journal-title":"Open Med"},{"key":"6572_CR52","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1093\/cid\/cit521","volume":"57","author":"CM Durand","year":"2013","unstructured":"Durand CM, Marr KA, Arnold CA et al (2013) Detection of cytomegalovirus DNA in plasma as an adjunct diagnostic for gastrointestinal tract disease in kidney and liver transplant recipients. Clin Infect Dis 57:1550\u20131559. https:\/\/doi.org\/10.1093\/cid\/cit521","journal-title":"Clin Infect Dis"},{"key":"6572_CR53","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.1097\/MEG.0000000000000906","volume":"29","author":"N Prachasitthisak","year":"2017","unstructured":"Prachasitthisak N, Tanpowpong P, Lertudomphonwanit C et al (2017) Short article: stool cytomegalovirus polymerase chain reaction for the diagnosis of cytomegalovirus-related gastrointestinal disease. Eur J Gastroenterol Hepatol 29:1059. https:\/\/doi.org\/10.1097\/MEG.0000000000000906","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"6572_CR54","doi-asserted-by":"publisher","first-page":"e00574","DOI":"10.14309\/ctg.0000000000000574","volume":"14","author":"O Sattayalertyanyong","year":"2023","unstructured":"Sattayalertyanyong O, Limsrivilai J, Phaophu P et al (2023) Performance of cytomegalovirus real-time polymerase chain reaction assays of fecal and plasma specimens for diagnosing cytomegalovirus colitis. Clin Transl Gastroenterol 14:e00574. https:\/\/doi.org\/10.14309\/ctg.0000000000000574","journal-title":"Clin Transl Gastroenterol"},{"key":"6572_CR55","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/TP.0000000000002191","volume":"102","author":"CN Kotton","year":"2018","unstructured":"Kotton CN, Kumar D, Caliendo AM et al (2018) The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation. Transplantation 102:900. https:\/\/doi.org\/10.1097\/TP.0000000000002191","journal-title":"Transplantation"},{"key":"6572_CR56","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1007\/s40265-022-01677-4","volume":"82","author":"C Kang","year":"2022","unstructured":"Kang C (2022) Maribavir: first approval. Drugs 82:335\u2013340. https:\/\/doi.org\/10.1007\/s40265-022-01677-4","journal-title":"Drugs"},{"key":"6572_CR57","doi-asserted-by":"publisher","first-page":"1874","DOI":"10.1111\/ajt.13227","volume":"15","author":"X Ye","year":"2015","unstructured":"Ye X, Van JN, Munoz FM et al (2015) Noroviruses as a cause of diarrhea in immunocompromised pediatric hematopoietic stem cell and solid organ transplant recipients. Am J Transplant 15:1874\u20131881. https:\/\/doi.org\/10.1111\/ajt.13227","journal-title":"Am J Transplant"},{"key":"6572_CR58","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1111\/ctr.12820","volume":"30","author":"S Brakemeier","year":"2016","unstructured":"Brakemeier S, Taxeidi SI, D\u00fcrr M et al (2016) Clinical outcome of norovirus infection in renal transplant patients. Clin Transplant 30:1283\u20131293. https:\/\/doi.org\/10.1111\/ctr.12820","journal-title":"Clin Transplant"},{"key":"6572_CR59","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/TP.0b013e31821c9392","volume":"92","author":"D Roos-Weil","year":"2011","unstructured":"Roos-Weil D, Ambert-Balay K, Lanternier F et al (2011) Impact of norovirus\/sapovirus-related diarrhea in renal transplant recipients hospitalized for diarrhea. Transplantation 92:61. https:\/\/doi.org\/10.1097\/TP.0b013e31821c9392","journal-title":"Transplantation"},{"key":"6572_CR60","doi-asserted-by":"publisher","first-page":"107","DOI":"10.15171\/ijtmgh.2017.22","volume":"5","author":"EM Tan","year":"2017","unstructured":"Tan EM, Cawcutt KA, Zomok CD et al (2017) Activity of nitazoxanide against viral gastroenteritis: a systematic review. Int J Travel Med Glob Health 5:107\u2013112. https:\/\/doi.org\/10.15171\/ijtmgh.2017.22","journal-title":"Int J Travel Med Glob Health"},{"key":"6572_CR61","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.14594","volume":"36","author":"J Hedvat","year":"2022","unstructured":"Hedvat J, Salerno DM, Kovac D et al (2022) Nitazoxanide treatment for norovirus infection in solid organ transplant recipients. Clin Transplant 36:e14594. https:\/\/doi.org\/10.1111\/ctr.14594","journal-title":"Clin Transplant"},{"key":"6572_CR62","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13186","volume":"22","author":"K Haubrich","year":"2018","unstructured":"Haubrich K, Gantt S, Blydt-Hansen T (2018) Successful treatment of chronic norovirus gastroenteritis with nitazoxanide in a pediatric kidney transplant recipient. Pediatr Transplant 22:e13186. https:\/\/doi.org\/10.1111\/petr.13186","journal-title":"Pediatr Transplant"},{"key":"6572_CR63","unstructured":"CDC (2024) DPDx - Cryptosporidiosis. https:\/\/www.cdc.gov\/dpdx\/cryptosporidiosis\/index.html. Accessed 17 Jun 2024"},{"key":"6572_CR64","doi-asserted-by":"publisher","first-page":"2245","DOI":"10.1007\/s00467-009-1274-y","volume":"24","author":"F Bandin","year":"2009","unstructured":"Bandin F, Kwon T, Linas M-D et al (2009) Cryptosporidiosis in paediatric renal transplantation. Pediatr Nephrol 24:2245\u20132255. https:\/\/doi.org\/10.1007\/s00467-009-1274-y","journal-title":"Pediatr Nephrol"},{"key":"6572_CR65","unstructured":"Science Direct (n.d.) Inosine-5\u2032-monophosphate dehydrogenase - an overview. https:\/\/www.sciencedirect.com\/topics\/neuroscience\/inosine-5-monophosphate-dehydrogenase. Accessed 17 Jun 2024"},{"key":"6572_CR66","doi-asserted-by":"publisher","unstructured":"La Hoz RM, Morris MI; AST Infectious Diseases Community of Practice (2019) Intestinal parasites including Cryptosporidium, Cyclospora, Giardia, and Microsporidia, Entamoeba histolytica, Strongyloides, Schistosomiasis, and Echinococcus: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant 33:e13618. https:\/\/doi.org\/10.1111\/ctr.13618","DOI":"10.1111\/ctr.13618"},{"key":"6572_CR67","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1097\/INF.0b013e31826780f7","volume":"31","author":"I Krause","year":"2012","unstructured":"Krause I, Amir J, Cleper R et al (2012) Cryptosporidiosis in children following solid organ transplantation. Pediatr Infect Dis J 31:1135\u20131138. https:\/\/doi.org\/10.1097\/INF.0b013e31826780f7","journal-title":"Pediatr Infect Dis J"},{"key":"6572_CR68","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1111\/tid.12336","volume":"17","author":"D Bhadauria","year":"2015","unstructured":"Bhadauria D, Goel A, Kaul A et al (2015) Cryptosporidium infection after renal transplantation in an endemic area. Transpl Infect Dis 17:48\u201355. https:\/\/doi.org\/10.1111\/tid.12336","journal-title":"Transpl Infect Dis"},{"key":"6572_CR69","doi-asserted-by":"publisher","first-page":"ofab610","DOI":"10.1093\/ofid\/ofab610","volume":"9","author":"E Tomczak","year":"2022","unstructured":"Tomczak E, McDougal AN, White AC Jr (2022) Resolution of cryptosporidiosis in transplant recipients: review of the literature and presentation of a renal transplant patient treated with nitazoxanide, azithromycin, and rifaximin. Open Forum Infect Dis 9:ofab610. https:\/\/doi.org\/10.1093\/ofid\/ofab610","journal-title":"Open Forum Infect Dis"},{"key":"6572_CR70","doi-asserted-by":"publisher","DOI":"10.1111\/petr.14790","volume":"28","author":"SJ Kizilbash","year":"2024","unstructured":"Kizilbash SJ, Connolly H, Bartosh S et al (2024) Probiotic use in pediatric kidney transplant recipients: what are current practices, and are they evidence-based? A pediatric nephrology research consortium study. Pediatr Transplant 28:e14790. https:\/\/doi.org\/10.1111\/petr.14790","journal-title":"Pediatr Transplant"},{"key":"6572_CR71","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1136\/bmj.39272.581736.55","volume":"335","author":"RB Canani","year":"2007","unstructured":"Canani RB, Cirillo P, Terrin G et al (2007) Probiotics for treatment of acute diarrhoea in children: randomised clinical trial of five different preparations. BMJ 335:340. https:\/\/doi.org\/10.1136\/bmj.39272.581736.55","journal-title":"BMJ"},{"key":"6572_CR72","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1517\/14740338.2014.872627","volume":"13","author":"T Didari","year":"2014","unstructured":"Didari T, Solki S, Mozaffari S et al (2014) A systematic review of the safety of probiotics. Expert Opin Drug Saf 13:227\u2013239. https:\/\/doi.org\/10.1517\/14740338.2014.872627","journal-title":"Expert Opin Drug Saf"},{"key":"6572_CR73","doi-asserted-by":"publisher","DOI":"10.1111\/petr.13582","volume":"23","author":"SJ Kizilbash","year":"2019","unstructured":"Kizilbash SJ, Sudel B, Anderson JA, Verghese PS (2019) Use of oral immunoglobulins to treat diarrhea in pediatric kidney transplant recipients\u2014single-center experience and review of the literature. Pediatr Transplant 23:e13582. https:\/\/doi.org\/10.1111\/petr.13582","journal-title":"Pediatr Transplant"},{"key":"6572_CR74","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s40272-020-00389-0","volume":"22","author":"E Alexander","year":"2020","unstructured":"Alexander E, Hommeida S, Stephens MC et al (2020) The role of oral administration of immunoglobulin in managing diarrheal illness in immunocompromised children. Pediatr Drugs 22:331\u2013334. https:\/\/doi.org\/10.1007\/s40272-020-00389-0","journal-title":"Pediatr Drugs"},{"key":"6572_CR75","first-page":"651","volume":"14","author":"EJ Kanfer","year":"1994","unstructured":"Kanfer EJ, Abrahamson G, Taylor J et al (1994) Severe rotavirus-associated diarrhoea following bone marrow transplantation: treatment with oral immunoglobulin. Bone Marrow Transplant 14:651\u2013652","journal-title":"Bone Marrow Transplant"},{"key":"6572_CR76","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1177\/1078155214522313","volume":"21","author":"D Williams","year":"2015","unstructured":"Williams D (2015) Treatment of rotavirus-associated diarrhea using enteral immunoglobulins for pediatric stem cell transplant patients. J Oncol Pharm Pract 21:238\u2013240. https:\/\/doi.org\/10.1177\/1078155214522313","journal-title":"J Oncol Pharm Pract"},{"key":"6572_CR77","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1097\/IPC.0000000000000479","volume":"25","author":"MS Gelfand","year":"2017","unstructured":"Gelfand MS, Cleveland KO (2017) Oral serum-derived bovine immunoglobulin for management of infectious diarrhea due to norovirus and cryptosporidiosis in solid organ transplant patients. Infect Dis Clin Pract 25:218\u2013220. https:\/\/doi.org\/10.1097\/IPC.0000000000000479","journal-title":"Infect Dis Clin Pract"},{"key":"6572_CR78","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1111\/imj.13027","volume":"46","author":"JA Trubiano","year":"2016","unstructured":"Trubiano JA, Cheng AC, Korman TM et al (2016) Australasian Society of Infectious Diseases updated guidelines for the management of Clostridium difficile infection in adults and children in Australia and New Zealand. Intern Med J 46:479\u2013493. https:\/\/doi.org\/10.1111\/imj.13027","journal-title":"Intern Med J"},{"issue":"Suppl 2","key":"6572_CR79","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.cmi.2021.09.038","volume":"27","author":"J van Prehn","year":"2021","unstructured":"van Prehn J, Reigadas E, Vogelzang EH et al (2021) European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults. Clin Microbiol Infect 27(Suppl 2):S1\u2013S21. https:\/\/doi.org\/10.1016\/j.cmi.2021.09.038","journal-title":"Clin Microbiol Infect"},{"key":"6572_CR80","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1016\/j.cgh.2019.04.037","volume":"18","author":"MR Nicholson","year":"2020","unstructured":"Nicholson MR, Mitchell PD, Alexander E et al (2020) Efficacy of fecal microbiota transplantation for Clostridium difficile infection in children. Clin Gastroenterol Hepatol 18:612-619.e1. https:\/\/doi.org\/10.1016\/j.cgh.2019.04.037","journal-title":"Clin Gastroenterol Hepatol"},{"key":"6572_CR81","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.3389\/fmicb.2018.02622","volume":"9","author":"X Li","year":"2018","unstructured":"Li X, Gao X, Hu H et al (2018) Clinical efficacy and microbiome changes following fecal microbiota transplantation in children with recurrent Clostridium difficile infection. Front Microbiol 9:2622. https:\/\/doi.org\/10.3389\/fmicb.2018.02622","journal-title":"Front Microbiol"}],"container-title":["Pediatric Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00467-024-06572-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00467-024-06572-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T09:53:54Z","timestamp":1750758834000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00467-024-06572-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":81,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["6572"],"URL":"https:\/\/doi.org\/10.1007\/s00467-024-06572-6","relation":{},"ISSN":["0931-041X","1432-198X"],"issn-type":[{"value":"0931-041X","type":"print"},{"value":"1432-198X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}